Sino Biopharmaceutical (OTCMKTS:SBMFF) Sees Large Decrease in Short Interest

Sino Biopharmaceutical (OTCMKTS:SBMFF) saw a significant decline in short interest in January. As of January 15th, there was short interest totaling 78,955,359 shares, a decline of 25.1% from the December 31st total of 105,368,569 shares. Approximately 0.4% of the company’s stock are sold short. Based on an average trading volume of 40 shares, the short-interest ratio is currently 1,973,884.0 days. Based on an average trading volume of 40 shares, the short-interest ratio is currently 1,973,884.0 days. Approximately 0.4% of the company’s stock are sold short.

Sino Biopharmaceutical Price Performance

Shares of OTCMKTS SBMFF opened at $0.88 on Friday. Sino Biopharmaceutical has a fifty-two week low of $0.37 and a fifty-two week high of $1.24. The firm’s 50-day simple moving average is $0.88 and its 200 day simple moving average is $0.94.

Sino Biopharmaceutical Company Profile

Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.

The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.